Olin (OLN)
(Delayed Data from NYSE)
$53.48 USD
+0.66 (1.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $53.50 +0.02 (0.04%) 5:54 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.48 USD
+0.66 (1.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $53.50 +0.02 (0.04%) 5:54 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Zacks News
Olin (OLN) Q2 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Olin (OLN) beats on second-quarter earnings but misses on revenues due to lower volumes in its chemical businesses.
Olin (OLN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Olin (OLN) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Olin (OLN) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 8.65% and 7.97%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olin (OLN) Revises Q2 Outlook, Implements Restructuring
by Zacks Equity Research
Olin (OLN) revises second-quarter outlook, citing an extended plant turnaround and lower market participation, while implementing strategic restructuring to enhance financial resilience.
Strength Seen in Chemours (CC): Can Its 24.1% Jump Turn into More Strength?
by Zacks Equity Research
Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Olin's (OLN) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
Lower volumes in its chemical businesses hurt Olin's (OLN) Q1 top line.
Olin (OLN) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of -9.38% and 6.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
FMC (FMC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Olin (OLN) Q1 Earnings Expected to Decline
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Olin (OLN) to Close Epoxy Facilities in Restructuring Program
by Zacks Equity Research
Olin (OLN) decides to cease operations at its epoxy facilities as part of an ongoing restructuring program in response to lower demand for its epoxy products.
Company News for Jan 30, 2023
by Zacks Equity Research
Companies In The News Are: CVX, CHTR, INTC, OLN.
Olin's (OLN) Earnings Beat Estimates in Q4, Revenues Lag
by Zacks Equity Research
Lower volumes from chemical businesses hurt Olin's (OLN) top line in the fourth quarter.
Olin (OLN) Tops Q4 Earnings Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 0.70% and 2.37%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Q4 Earnings Slated on Jan 26: DOW, EMN & OLN
by Anindya Barman
Chemical companies' Q4 results are likely to have been driven by stable end-market demand and the benefits of strategic actions amid headwinds from input and energy cost inflation. Let's see how DOW, EMN and OLN are poised ahead of their earnings releases.
Why Olin (OLN) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Olin (OLN) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Olin (OLN) Up 10.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Olin (OLN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Olin's (OLN) Earnings Surpass Estimates in Q3, Sales Lag
by Zacks Equity Research
Olin (OLN) sees higher sales in its Chlor Alkali Products and Vinyls unit in Q3 on the back of higher pricing.
Olin (OLN) Q3 Earnings Beat Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 17.20% and 2.64%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Eastman Chemical (EMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Olin (OLN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Olin (OLN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is FMC (FMC) Down 0.9% Since Last Earnings Report?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JPUS